Collaborative R&D licensing and option agreement for disease altering therapies in oncology (extended)Collaborative R&d Licensing and Option Agreement • September 23rd, 2020
Contract Type FiledSeptember 23rd, 2020
DealdocCollaborative R&d, Licensing and Option Agreement • January 29th, 2022 • California
Contract Type FiledJanuary 29th, 2022 JurisdictionCollaborative R&D, licensing and option agreement for XmAb5871 monoclonal antibodies for autoimmune diseases (terminated)